The biggest unresolved question in #pancreatology: After #EUS drainage of infected #WON — who needs necrosectomy, when should it happen, and how aggressive should you be? Three new papers address each part of that question. #GITwitter#Pancreas#Endoscopy
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
Abdominal surgery in a patient with cirrhosis? The EASL guideline (2025) updates the management.🩺
Key message: risk stratification must be multimodal. The VOCAL-Penn score is recommended over classic Child-Pugh or MELD for elective surgical decisions.
🔗 https://t.co/UoWqhFy69o